Re: Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity

被引:0
|
作者
Elliott, Sean P.
机构
来源
JOURNAL OF UROLOGY | 2023年 / 209卷 / 01期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:289 / 289
页数:1
相关论文
共 50 条
  • [41] Botulinum Toxin A (Botox) Intradetrusor Injections in Adults With Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review Editorial Comment
    Karsenty, G.
    Denys, P.
    Amarenco, G.
    De Seze, M.
    Game, X.
    Haab, F.
    Kerdraon, J.
    Perrouin-Verbe, B.
    Ruffion, A.
    Saussine, C.
    Soler, J. M.
    Schurch, B.
    Chartier-Kastler, E.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 1802 - 1802
  • [42] Re: Switch to Abobotulinum Toxin A May be Useful in the Treatment of Neurogenic Detrusor Overactivity when Intradetrusor Injections of Onabotulinum Toxin A Failed Editorial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 451 - 452
  • [43] SWITCH TO ABOBOTULINUM TOXIN A MAY BE USEFUL IN THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY WHEN INTRADETRUSOR INJECTIONS OF ONABOTULINUM TOXIN A FAILED
    Peyronnet, Benoit
    Bottet, Florie
    Boissier, Romain
    Manunta, Andrea
    Reiss, Benedicte
    Previnaire, Jean-Gabriel
    Kerdraon, Jacques
    Ruffion, Alain
    Lenormand, Loic
    Perrouin-Verbe, Brigitte
    Gaillet, Sarah
    Game, Xavier
    Karsenty, Gilles
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1261 - E1262
  • [44] Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed
    Bottet, Florie
    Peyronnet, Benoit
    Boissier, Romain
    Reiss, Benedicte
    Previnaire, Jean G.
    Manunta, Andrea
    Kerdraon, Jacques
    Ruffion, Alain
    Lenormand, Loic
    Verbe, Brigitte Perrouin
    Gaillet, Sarah
    Game, Xavier
    Karsenty, Gilles
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (01) : 291 - 297
  • [45] Re: Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity
    Conte, A.
    Giannantoni, A.
    Proietti, S.
    Giovannozzi, S.
    Fabbrini, G.
    Rossi, A.
    Porena, M.
    Berardelli, A.
    JOURNAL OF UROLOGY, 2014, 191 (05): : 1340 - 1341
  • [46] Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity
    Kaviani, Aaron
    Khavari, Rose
    UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (03) : 463 - +
  • [47] Botulinum Toxin Therapy for Neurogenic Detrusor Overactivity
    Smaldone, Marc C.
    Ristau, Benjamin T.
    Leng, Wendy W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2010, 37 (04) : 567 - +
  • [48] Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results
    Patel, Arland K.
    Patterson, Jacob M.
    Chapple, Christopher R.
    EUROPEAN UROLOGY, 2006, 50 (04) : 684 - 710
  • [49] Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: Urodynamic outcome and patient satisfaction
    Ghalayini, Ibrahim Fathi
    Al-Ghazo, Mohammed A.
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (04) : 531 - 536
  • [50] Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury
    Guoqing Chen
    Limin Liao
    International Urology and Nephrology, 2011, 43 : 655 - 662